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a b s t r a c t 
4-Hydroxy-2-( E )-nonenal (4-HNE) is one of the major lipid peroxidation product formed during oxidative
stress. At high concentrations, 4-HNE is cytotoxic and exerts deleterious effects that are often associated
with the pathology of oxidative stress-driven disease. Alternatively, at low concentrations it functions as
a signaling molecule that can activate protective pathways including the antioxidant Nrf2-Keap1 pathway.
Although these biphasic signaling properties have been enumerated in many diseases and pathways, it has
yet to be addressed whether 4-HNE has the capacity to modulate oxidative stress-driven lipid peroxidation.
Here we report an auto-regulatory mechanism of 4-HNE via modulation of the biological oxidant nitric oxide
(NO). Utilizing LPS-activated macrophages to induce biological oxidant production, we demonstrate that 4-
HNE modulates NO levels via inhibition of iNOS expression. We illustrate a proposed model of control of NO
formation whereby at low concentrations of 4-HNE a negative feedback loop maintains a constant level of NO
production with an observed inﬂection at approximately 1 μM, while at higher 4-HNE concentrations positive
feedback is observed. Further, we demonstrate that this negative feedback loop of NO production control is
dependent on the Nrf2-Keap1 signaling pathway. Taken together, the careful regulation of NO production by
4-HNE argues for a more fundamental role of this lipid peroxidation product in normal physiology. 
c © 2014 The Authors. Published by Elsevier B.V.
This is an open access article under the CC BY-NC-SA license
( http: // creativecommons.org / licenses / by-nc-sa / 3.0 / ). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Introduction 
Polyunsaturated fatty acids (PUFAs) may undergo both enzymatic
and non-enzymatic lipid peroxidation leading to unsaturated lipid
hydroperoxides (LOOHs). The aforementioned enzymatic processes
are mediated by members of the lipoxygenase family and lead to the
formation of a family of physiologic mediators of inﬂammation, such
as leukotrienes and prostaglandins [ 3 , 11 , 20 , 30 ]. The latter represents
an altogether different and much less understood process whereby
PUFAs, under conditions of oxidative stress, can spontaneously form
peroxides at the allylic (or doubly allylic) positions initiated by a
free radical hydrogen abstraction of a number of physiologic lipids
[ 34 , 35 ]. These lipid peroxides can subsequently undergo a variety of* Corresponding author at: Department of Pharmacology, Case Western Reserve 
University, 10900 Euclid Avenue, Cleveland, OH 44106, USA. 
E-mail address: tochtrop@case.edu (G.P. Tochtrop). 
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by-nc-sa / 3.0 / ). 
http://dx.doi.org/10.1016/j.redox.2014.04.009 secondary reactions, some leading to stable oxygenated and polyoxy-
genated acyl chains, while others lead to chain cleavage and prod-
ucts containing either a methyl or carboxy terminus. 4-Hydroxy-2-
( E )-nonenal (4-HNE) is the most abundant of the known lipid per-
oxidation (LPO) products and is an established marker of oxidative
stress. The pathogenicity of this reactive aldehyde has been ratio-
nalized through the formation of adducts with nucleophilic sites on
proteins and DNA [ 27 , 38 ] and has become accepted as a modula-
tor of multiple disease states, including Alzheimer ’ s disease [ 2 , 7 ],
atherosclerosis [ 5 , 37 , 42 ], and cancer [ 29 ]. However, the recent view
regarding 4-HNE has evolved to appreciate the complex physiology
and signaling aspects of this molecule [ 14 , 28 , 32 ]. 
To better understand these signaling properties and to explore
whether 4-HNE could impact the formation of biological oxidants,
we initiated a series of experiments examining the relationship be-
tween 4-HNE concentrations and the ability of activated cultured
macrophages to produce nitric oxide (NO). Our rationale behind these
experiments was based on previous work showing that 4-HNE acti-
vates the antioxidant Nrf2-Keap1 signaling pathway due to its elec-
trophilic nature [ 8 , 19 , 21 ]. This coupled with our own work [ 16 ] as access article under the CC BY-NC-SA license ( http: // creativecommons.org / licenses / 
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 ell as others [ 12 , 23 ] showing that molecules which activate Nrf2 
ranscription also perturb inducible nitric oxide synthase (iNOS) ex- 
ression and thus production of NO set the basis for the experiments 
escribed herein. 
xperimental Section 
aterials 
The leukemic mouse macrophage cells (RAW 264.7) were obtained 
s a gift from Dr. Michael Sporn (Dartmouth College, NH). DMEM me- 
ia was purchased from GIBCO (Grand Island, NY) and supplemented 
ith low endotoxin FBS ( < 0.06 EU) from Thermo Scientiﬁc (Lo- 
an, UT). DMSO, lipopolysaccharide (LPS) from Escherichia coli , and 
on-enzymatic cell detachment solution were purchased from Sigma 
St. Louis, MO). Penicillin / streptomycin, Griess Reagent Kit (Griess 
ssay), RIPA Buffer, 0.2 μm PVDF membrane, Novex 
®
4–20% Tris–
lycine gels, running and transfer buffers, PureLink TM RNA Mini Kit, 
uperscript 
®
III Reverse Transcriptase and TaqMan 
®
Fast Univer- 
al PCR Master Mix were all purchased from Invitrogen (Grand Is- 
and, NY). All the primary antibodies were purchased from Santa Cruz 
iotechnology (Santa Cruz, CA) and secondary antibodies from South- 
rn Biotech (Birmingham, AL). Recombinant mouse M-CSF was pur- 
hased from PeproTech (Rocky Hill, NJ). Protease cocktail inhibitor 
ablet was purchased from Roche (Indianapolis, IN) and PBS pur- 
hased from Cellgro by Mediatech, Inc. (Manassas, VA). The ECL plus 
as purchased from Amersham (Buckinghamshire, UK) and the au- 
oradiography ﬁlm was from MidSci (St. Louis, MO). The MTT cell 
roliferation assay kit was purchased from ATCC (Manassas, VA). The 
NOS probe was purchased from Applied Biosystems (Carlsbad, CA), 
nd the 18s rRNA probe was purchased from IDT (Coralville, IA). The 
NOS activity kit and the murine recombinant iNOS were purchased 
rom Cayman Chemicals (Ann Arbor, MI) and the [ 3 H] arginine mono- 
ydrochloride from PerkinElmer (Waltham, MA). 
eneral methods for synthesis 
Unless otherwise stated, the solvents and reagents were commer- 
ially available analytical grade quality and used without further pu- 
iﬁcation. Flash chromatography was performed on silica gel (230–
00 mesh) purchased from Dynamics Adsorbents (Atlanta, GA). TLC 
as done on Hard Layer, Organic Binder TLC-plates with a ﬂuorescent 
ndicator and visualized by UV light (254 nm) purchased from Dynam- 
cs Adsorbents (Atlanta, GA). 1 H and 13 C NMR spectra were recorded 
n a Varian Inova spectrometer (at the Department of Chemistry, Case 
estern Reserve University) operating at 400 MHz and 100 MHz for 
he 1 H and 13 C NMR spectra, respectively. The internal references 
ere TMS ( δ 0.00) and CDCl 3 ( δ 77.2) for 1 H and 13 C spectra, respec- 
ively. NMR data are presented in the following order: chemical shift, 
eak multiplicity (b is the broad, s is the singlet, d is the doublet, 
 is the triplet, q is the quartet, m is the multiplet, dd is the doublet of 
oublet), coupling constant, and proton number. 
umaraldehyde dimethylacetal (FDMA, 2) 
Fumaraldehyde dimethylacetal, (FDMA, 2 ) was obtained by partial 
cid hydrolysis of fumaraldehyde bis(dimethylacetal), (FbisDMA, 1 ). 
mberlyst-15 catalyst in acid form (0.06 g) was added to the FbisDMA 
 (0.2 g, 1.135 mmol) in acetone (6 mL) and water (0.08 mL) under 
agnetic stirring at room temperature. Stirring was continued for 
0 min (longer time resulted in the hydrolysis of the second acetal 
roup), then the reaction mixture was ﬁltered through a bed of anhy- 
rous sodium carbonate and sodium sulfate 1:1 (w:w) followed by the 
olvent evaporation in vacuo to obtain FDMA [ 2 ] (0.14 g, 1.076 mmol, 
5% yield). NMR data were in accord with the literature [ 10 ]. 4-Hydroxy-2-(E)-pentenal (4-HPE, 3) 
A solution of aldehyde, FDMA [ 2 ] (0.14 g, 1.076 mmol) in dry 
THF (6 mL) was cooled to −78 ◦C, and 0.8 mL of MeLi (1.6 M so- 
lution in Et 2 O, 1.28 mmol) was added slowly. The solution was 
stirred for 30 min followed by work-up with saturated solution of 
NH 4 Cl at −78 ◦C. The reaction mixture was then extracted with Et 2 O 
(3 × 10 mL), the combined organic layers were dried over Na 2 SO 4 , 
and the solvent was removed in vacuo to obtain the crude product. 
The latter was then hydrolyzed with Amberlyst-15 as described for 
FDMA [ 2 ] to afford the crude 4-hydroxy-2-( E )-pentenal (4-HPE, 3 ), 
which was then puriﬁed by column chromatography over silica (hex- 
ane, 30% ethyl acetate) to give 4-HPE [ 3 ] (0.083 g, 0.829 mmol, 77%). 
1 H NMR (400 MHz, CDCl 3 ): 1.39 (d, 3H, J = 6.8 Hz), 4.61 (m, 1H), 
6.29 (ddd, 1H, J = 15.6, 7.6, 1.6 Hz), 6.84 (dd, 1H, J = 15.6, 4.8 Hz), 
9.57 (d, 1H, J = 7.6 Hz); 13 C NMR (100 MHz, CDCl 3 ): 22.7, 67.3, 130.2, 
160.1, 193.9. EI-HRMS (positive mode): m / z Calcd. for C 5 H 9 O 2 [MH 
+ ] 
101.0602, found 101.0602. 
General method for 4-haydroxy-2-(E)-alkenals (3a–3g) 
4-Hydroxy-2-( E )-alkenals, 3a–3g were synthesized using the 
Gardner method (see Fig. 2 A) [ 15 ]. To a stirring solution of 3-alkenol, 
4a–4g (1 mmol) in 4 mL CH 2 Cl 2 was added a 1.5 M excess of 70% m -
chloroperoxybenzoic acid (0.37 g). The solution was stirred at room 
temperature for 1.5 h after which 4 mL of 10% NaHCO 3 was added 
with vigorous stirring for 45 min. The reaction mixture was then ex- 
tracted with CH 2 Cl 2 (3 × 15 mL), the combined organic layers were 
dried over Na 2 SO 4 , and the solvent was removed in vacuo to obtain 
the crude product which was redissolved in 5 mL of CH 2 Cl 2 and 6.6 mL 
of Dess–Martin periodinane (0.3 M solution in CH 2 Cl 2 , 2 mmol) was 
added. The mixture was stirred for 2 h at room temperature and then 
15 mL of Et 2 O and 8 mL of 1.3 M NaOH Was added into that and 
vigorously stirred for 1 min. The aqueous NaOH layer was removed, 
and an additional 10 mL of 1.3 M NaOH were added with vigorous 
stirring for 15 min. The aqueous layer was removed and the organic 
phase was washed with brine solution. The organic layer was dried 
over Na 2 SO 4 , and the solvent was removed in vacuo to obtain the 
crude 4-hydroxy-2-( E )-alkenal, which was then puriﬁed by column 
chromatography over silica (hexane, 30–40% ethyl acetate) to give 
pure 4-hydroxy-2-( E )-alkenal, 3a–3g . 
4-Hydroxy-2-(E)-hexenal (4-HHE, 3a) 
Overall yield: 42.1% (0.048 g, 0.421 mmol); 1 H NMR (400 MHz, 
CDCl 3 ): 0.98 (t, 3H, J = 7.6 Hz), 1.57–1.74 (m, 2H), 4.36 (m, 1H), 
6.29 (ddd, 1H, J = 15.6, 8.0, 1.6 Hz), 6.82 (dd, 1H, J = 15.6, 4.8 Hz), 
9.55 (d, 1H, J = 8.0 Hz); 13 C NMR (100 MHz, CDCl 3 ): 9.6, 29.5, 72.3, 
130.9, 159.3, 193.9. EI-HRMS (positive mode): m / z Calcd. for C 6 H 11 O 2 
[MH + ] 115.0756, found 115.0756. 
4-Hydroxy-2-(E)-heptenal (4-HHE, 3b) 
Overall yield: 40% (0.051 g, 0.40 mmol); 1 H NMR (400 MHz, CDCl 3 ): 
0.92 (t, 3H, J = 7.6 Hz), 1.32–1.61 (m, 4H), 4.41 (m, 1H), 6.27 (ddd, 
1H, J = 15.6, 8.0, 1.6 Hz), 6.82 (dd, 1H, J = 15.6, 4.8 Hz), 9.52 (d, 
1H, J = 8.0 Hz); 13 C NMR (100 MHz, CDCl 3 ): 14.1, 18.7, 38.6, 70.9, 
130.6, 160.1, 194.2. EI-HRMS (positive mode): m / z Calcd. for C 7 H 13 O 2 
[MH + ] 129.0915, found 129.0919. 
4-Hydroxy-2-(E)-octenal (4-HOE, 3c) 
Overall yield: 43% (0.061 g, 0.43 mmol); 1 H NMR (400 MHz, CDCl 3 ): 
0.89 (t, 3H, J = 7.6 Hz), 1.28–1.66 (m, 6H), 4.40 (m, 1H), 6.28 (ddd, 
1H, J = 15.6, 8.0, 1.6 Hz), 6.82 (dd, 1H, J = 15.6, 4.8 Hz), 9.53 (d, 1H,
J = 8.0 Hz); 13 C NMR (100 MHz, CDCl 3 ): 14.1, 22.7, 27.5, 36.3, 71.2, 
130.7, 159.9, 194.1. EI-HRMS (positive mode): m / z Calcd. for C 8 H 15 O 2 
[MH + ] 143.1072, found 143.1078. 
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Fig. 1. Nitrite levels in 4-HNE treated LPS-activated RAW 264.7 cells. Nitrite levels 
were measured via Griess assay in cells simultaneously activated with 10 ng / mL LPS 
and treated with varying concentrations of 4-HNE for (A) 24 h and (B) 30 min. 0.25% 
DMSO was used as control. Experiments were performed at least 3 times and error bars 
represent standard error of mean. * P < 0.05; *** P < 0.001. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 4-Hydroxy-2-(E)-nonenal (4-HNE, 3d) 
Overall yield: 46% (0.072 g, 0.46 mmol); 1 H NMR (400 MHz, CDCl 3 ):
0.94 (t, 3H, J = 7.6 Hz), 1.29–1.68 (m, 8H), 4.41 (m, 1H), 6.27 (ddd,
1H, J = 15.6, 8.0, 1.6 Hz), 6.82 (dd, 1H, J = 15.6, 4.8 Hz), 9.51 (d, 1H,
J = 8.0 Hz); 13 C NMR (100 MHz, CDCl 3 ): 14.2, 22.7, 25.1, 31.8, 36.6,
71.3, 130.7, 159.6, 194.0. EI-HRMS (positive mode): m / z Calcd. for
C 9 H 17 O 2 [MH 
+ ] 157.1228, found 157.1231. 
4-Hydroxy-2-(E)-decenal (4-HDE, 3e) 
Overall yield: 39% (0.066 g, 0.39 mmol); 1 H NMR (400 MHz, CDCl 3 ):
0.90 (t, 3H, J = 7.6 Hz), 1.29–1.65 (m, 10H), 4.44 (m, 1H), 6.31 (ddd,
1H, J = 15.6, 8.0, 1.6 Hz), 6.84 (dd, 1H, J = 15.6, 4.8 Hz), 9.57 (d, 1H,
J = 8.0 Hz); 13 C NMR (100 MHz, CDCl 3 ): 14.2, 22.7, 25.3, 29.2, 31.8,
36.6, 71.3, 130.7, 159.5, 194.0. EI-HRMS (positive mode): m / z Calcd.
for C 10 H 19 O 2 [MH 
+ ] 171.1385, found 171.1388. 
4-Hydroxy-2-(E)-undecenal (4-HUE, 3f) 
Overall yield: 41% (0.076 g, 0.41 mmol); 1 H NMR (400 MHz, CDCl 3 ):
0.90 (t, 3H, J = 7.6 Hz), 1.28–1.67 (m, 12H), 4.43 (m, 1H), 6.32 (ddd,
1H, J = 15.6, 8.0, 1.6 Hz), 6.83 (dd, 1H, J = 15.6, 4.8 Hz), 9.58 (d, 1H,
J = 8.0 Hz); 13 C NMR (100 MHz, CDCl 3 ): 14.2, 22.8, 25.4, 29.3, 29.5,
31.9, 36.7, 71.3, 130.8, 159.4, 193.9. EI-HRMS (positive mode): m / z
Calcd. for C 11 H 21 O 2 [MH 
+ ] 181.1541, found 181.1541. 4-Hydroxy-2-(E)-dodecenal (4-HDoE, 3g) 
Overall yield: 44% (0.087 g, 0.44 mmol); 1 H NMR (400 MHz, CDCl 3 ):
0.92 (t, 3H, J = 7.6 Hz), 1.25–1.66 (m, 14H), 4.44 (m, 1H), 6.31 (ddd,
1H, J = 15.6, 8.0, 1.6 Hz), 6.84 (dd, 1H, J = 15.6, 4.8 Hz), 9.58 (d, 1H,
J = 8.0 Hz); 13 C NMR (100 MHz, CDCl 3 ): 14.3, 22.8, 25.4, 29.4, 29.6,
29.7, 32.0, 36.7, 71.3, 130.8, 159.3, 193.8. EI-HRMS (positive mode):
m / z Calcd. for C 12 H 23 O 2 [MH 
+ ] 199.1698, found 199.1702. 
3-Alken-1-ol (4a-4g) 
4a–4d were purchased from TCI America. The cis -3-decen-1-ol
( 4e ) was obtained by catalytic semi hydrogenation (1 atm) of a solu-
tion of 3-decyn-1-ol. 3-Decyn-1-ol (1 g, 6.483 mmol) was dissolved
in dry Et 2 O (25 mL) in a small round bottom ﬂask. Lindlar catalyst
(50 mg, Pd on CaCO 3 ) and 1 g of quinoline were added and hydrogen
was supplied from balloons. After completion of the reaction (con-
ﬁrmed by NMR) the mixture was ﬁltered to remove the catalyst and
the solvent was removed on a rotary evaporator. Dichloromethane
was added to the residue and washed with 1M acetic acid, brine, and
water, and dried with Na 2 SO 4 . The crude was then puriﬁed by column
chromatography over silica (dichloromethane, 1% methanol) to afford
cis -3-decen-1-ol, 4e (0.932 g, 5.964 mmol, 92%). 1 H NMR (400 MHz,
CDCl 3 ): 0.89 (t, 3 H , J = 6.8 Hz), 1.23–1.55 (m, 8 H), 2.08 (td, 2 H , J = 6.8,
6.6 Hz), 2.37 (td, 2 H , J = 6.6, 6.4 Hz), 3.63 (td, 2 H , J = 5.8, 5.6 Hz),
5.31–5.39 (m, 1 H), 5.51–5.63 (m, 1 H); 13 C NMR (100 MHz, CDCl 3 ):
14.1, 22.6, 27.3, 29.0, 29.6, 30.8, 31.8, 62.4, 124.8, 133.8. 
Trans-3-undecen-1-ol 
( 4f ) and trans-3-dodecen-1-ol ( 4 g ) were synthesized using a Kno-
evenagel condensation of nonanal or decanal and malonic acid [ 31 ]
followed by LiAlH 4 reduction. Malonic acid (2.03 g, 19.5 mmol) was
dissolved in triethylamine (2.97 g, 29.27 mmol) in a 2-neck round-
bottom ﬂask ﬁtted with a magnetic stirring bar and a reﬂux condenser.
Nonanal (2.77 g, 19.5 mmol) was added very slowly under inert atmo-
sphere at room temperature. The reaction mixture was then heated
to 80 ◦C and maintained at this temperature for 3 h. The product
was then acidiﬁed with 1 M HCl and extracted with Et 2 O. Organic
layers were thoroughly washed with brine and water and dried over
Na 2 SO 4 . Solvent was removed in vacuo to obtain trans-3-undecenoic
acid (2.91 g, 15.8 mmol, 81%). The crude product was pure enough
to perform the next step. The LiAlH 4 (0.93 g, 24.5 mmol) was dis-
solved in 15 mL dry THF, stirred for 5 min under inert atmosphere.
Trans-3-undecenoic acid (1.5 g, 8.15 mmol) was dissolved in 5 mL
THF and added slowly. The reaction was allowed to continue for 4 h
under inert atmosphere, then 2 mL H 2 O was added to quench the
reaction, and 1 M HCl was added until pH < 3. Most of the THF was
removed in vacuo , and the residue was diluted with 10 mL H 2 O, and
extracted with CH 2 Cl 2 (3 × 30 mL). The combined organic layers
were dried with Na 2 SO 4 , and the solvent was removed in vacuo . The
resulting residue was puriﬁed by column chromatography over sil-
ica (hexane, 30% ethyl acetate) to give pure trans-3-undecen-1-ol 4f
(1.3 g, 7.7 mmol, 94%). The trans-3-dodecen-1-ol 4g was also syn-
thesized following the same method as for 4f and had comparable
yield. 
Trans-3-undecen-1-ol (4f) 
1 H NMR (400 MHz, CDCl 3 ): 0.88 (t, 3H, J = 6.8 Hz), 1.27–1.39 (m,
10H), 2.01 (q, 2H, J = 6.4 Hz), 2.26 (q, 2H, J = 6.4 Hz), 3.61 (t, 2H,
J = 6.4 Hz), 5.37 (dt, 1H, J = 15.2, 7.2 Hz), 5.55 (dt, 1H, J = 15.2, 6.8 Hz);
13 C NMR (100 MHz, CDCl 3 ): 14.2, 22.8, 29.3, 29.4, 29.6, 32.0, 32.8,
36.1, 62.2, 125.8, 134.4. 
Trans-3-dodecen-1-ol (4g) 
1 H NMR (400 MHz, CDCl 3 ): 0.88 (t, 3H, J = 7.2 Hz), 1.22–1.37 (m,
12 H), 2.01 (q, 2H, J = 6.4 Hz), 2.26 (q, 2H, J = 6.4 Hz), 3.62 (t, 2H,
J = 6.4 Hz), 5.37 (dt, 1H, J = 15.2, 7.2 Hz), 5.56 (dt, 1H, J = 15.2, 6.8 Hz);
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Fig. 2. Synthesis and activity of C5 −C12 4-hydroxy-2- (E) -alkenal derivatives. (A) Syn- 
thesis of 4-hydroxy-2- (E) -alkenal derivatives C5 −C12 . 4-HPE [ 3 ] is described as C5 in 
the text and compounds 3a–3g represents C6 to C12 where n = 0–6 correspondingly. 
(B) Nitrite levels from LPS-activated macrophage treated with 1 μM 4-hydroxy-2- (E) - 
alkenal derivatives C5 −C12 for 24 h. Experiments were performed at least 3 times and 
error bars represent standard error of mean. ** P < 0.01. 
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 3 C NMR (100 MHz, CDCl 3 ): 14.3, 22.8, 29.4, 29.5, 29.7, 29.7, 32.1, 
2.8, 36.1, 62.2, 125.8, 134.6. 
ell culture 
RAW 264.7 cells were cultured in DMEM media supplemented 
ith 10% FBS and 1% penicillin / streptomycin and kept in culture at 
7 ◦C in a 5% CO 2 environment. Cells were kept in culture for no longer 
han a month and routinely checked for LPS responsiveness every two 
o three passages via detection of nitrite production measured using 
he Griess assay. 
ell viability measurement 
Remaining cells from the Griess assay were used for viability mea- 
urement using the MTT Cell Proliferation assay kit from ATCC fol- 
owing manufacturer ’ s instruction. Absorbance was read at 550 nm 
sing the Sunrise TM plate reader by TECAN. Percent viability of treated 
ells was calculated relative to the LPS-activated treated with DMSO 
ontrol as 100% viability. 
itrite level measurement 
RAW 264.7 cells were plated at 1 × 10 6 cells / well in a 96- 
ell plate and allowed to attach for 3 h before simultaneous acti- 
ation with 10 ng / mL LPS and treated with 4-hydroxy-2-( E )-alkenal 
erivatives ( C5–C12 , C9 being 4-HNE) or 0.25% DMSO control. 4- 
ydroxy-2-( E )-alkenal derivatives were freshly made in DMSO. LPS- 
ctivated cells were treated with varying concentrations of 4-HNE for 
ither 30 min or 24 h. For studies of other 4-hydroxy-2-( E )-alkenal 
erivatives, LPS-activated cells were treated with 1 μM derivatives 
or 24 h. Nitrite levels were measured via Griess assay according 
o manufacturer ’ s speciﬁcations using 100 μL Griess reagent with 100 μL sample supernatant. Absorbance was read at 550 nm using 
the Sunrise TM plate reader by TECAN (Mannedorf, Switzerland). 
Immunoblot analysis 
RAW 264.7 cells were plated at 4 × 10 6 cells / 60 mm plate and 
allowed to attach for 3 h. Cells were activated with 10 ng / mL LPS and 
treated with varying concentrations of 4-HNE, DMSO control, or LPS 
with DMSO control and harvested for immunoblot analysis and quan- 
titative RT-PCR. Proteins were isolated via lysing the cells with RIPA 
Buffer containing protease inhibitors and equal amounts of proteins 
were loaded into a Novex 4–20% Tris–Glycine gel. Proteins were trans- 
ferred to a PVDF membrane, blocked with 5% non-fat dry skim milk 
in 0.5% Tris-buffered saline containing Tween-20 (TBST), and probed 
with antibodies. Primary antibodies were diluted 1:500 to 1:1000 and 
secondary horse-radish peroxidase antibodies were diluted 1:5000. 
Antibodies were detected using ECL plus with autoradiography. 
Quantitative RT-PCR 
Cells harvested for the immunoblot analysis were also har- 
vested for quantitative RT-PCR. Total RNA was extracted using the 
PureLink TM RNA Mini Kit followed by reverse transcription reac- 
tion using the Superscript 
®
III Reverse Transcriptase. PCR was per- 
formed using TaqMan 
®
Gene Expression Assay iNOS, HO-1, NQO1 
and GCLC probes (Assay ID: Mm01309902 m1, Mm00516007 m1, 
Mm00500821 m1, Mm00802655 m1, respectively), PrimeTime qPCR 
assay (Assay ID: Mm.PT.42.122532.g) 18s rRNA control probe with 
TaqMan 
®
Fast Universal PCR Master Mix. Ampliﬁcation was per- 
formed using the 7500 Fast Real-Time PCR system (95 ◦C for 20 s, 
followed by 40 cycles of 95 ◦C for 3 s, and 60 ◦C for 30 s) and the
7500 Fast System SDS Software-Sequence Detection Software version 
1.3.1.21 by Applied Biosystems. 
iNOS activity assay 
iNOS activity was measured using the iNOS activity kit via detec- 
tion of radiolabeled arginine (arginine monohydrochloride L-[2,3,4- 
3 H]) conversion to L-citrulline. Reactions were prepared according to 
manufacturer ’ s instructions using the iNOS (murine recombinant) en- 
zyme. Each reaction was treated with various 4-HNE concentrations 
and allowed to proceed at room temperature for 1 h. Radioactivity was 
quantiﬁed by counts per minute (CPM) with 1450 MicroBeta TriLux 
Microplate Scintillation Counter. The positive control contained iNOS 
enzyme, and the negative control contained the iNOS enzyme treated 
with a NOS competitive inhibitor L-N G -nitroarginine (L-NNA). 
Bone marrow derived macrophage isolation and treatment 
Bone marrow derived macrophages (BMDM) from 6–8 week old 
C57BL / J6 mice (wild-type) and Nrf2 knockout mice (Nrf2 −/ −) were 
isolated and plated in DMEM medium supplemented with 10% FBS, 
1% penicillin / streptomycin and M-CSF. Fresh medium containing M- 
CSF was added after 3 days of incubation. Cells were washed with 
PBS 2–3 times to remove non-macrophage cells and a non-enzymatic 
detaching solution was used to collect BMDM. Cells were plated at 
4 × 10 6 cells / 60 mm plate in DMEM medium supplemented with 10% 
FBS and 1% penicillin / streptomycin, and cultured overnight. BMDM 
were activated with 500 ng / mL LPS and treated with varying concen- 
trations of 4-HNE or 0.05% DMSO control. Cells were harvested for 
Griess assay and MTT analysis after a 48 h treatment. All experiments 
performed were in accordance with an approved protocol by the In- 
stitutional Animal Care and Use Committee at Case Western Reserve 
University. 
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Fig. 3. (A) iNOS activity was measured via quantiﬁcation of radiolabeled L-arginine to L-citrulline conversion. iNOS enzyme alone served as positive control while iNOS enzyme 
treated with N ω -nitro-L-arginine (L-NNA) inhibitor served as negative control. (B) Immunoblot analysis of iNOS protein levels in 4-HNE treated LPS-activated macrophage treated 
for 18 h. DMSO treated cells were used as negative control while DMSO treated LPS-activated cells were used as positive control. β-actin was used as protein loading control. (C) 
mRNA levels of 4-HNE treated LPS-activated macrophage treated for 18 h. Fold change in expression were calculated relative to DMSO treated LPS-activated iNOS expression which 
was normalized to 18s rRNA expression. Experiments were performed at least 3 times and error bars represent standard error of mean. *** P < 0.001. 
Fig. 4. (A) Immunoblot analysis of Nrf2 protein levels in the cytoplasm and nucleus. RAW 264.7 cells were treated with increasing concentrations of 4-HNE for 5 min. β-actin and 
lamin B1 were used as loading controls. (B) mRNA levels of 4-HNE treated macrophage were treated for 4 h. Fold change in expression was calculated relative to DMSO treated 
HO-1, NQO1, and GCLC expression which was normalized to 18s rRNA expression. Experiments were performed at least 3 times and error bars represent standard error of mean. 
** P < 0.01. 
 
 
 
 
 
 
 
 
 
 
 
 Conjugated 4-HNE-GSH LC-MS measurement 
4-hydroxydecanenal-GSH, and 4-HNE-GSH Michael addition
adducts were assayed from our previously published methods,
with modiﬁcation [ 1 , 22 , 33 , 43 ]. Brieﬂy, media (1 mL) or cell lysates
(32.5 μL) from 4-HNE treated RAW 264.7 cells for 15 min or 18 h
were spiked with 0.25 nmol of 4-hydroxydecanenal-GSH (internal
standard). Media from culture and cell lysates were treated with 4 or0.2 mL acetonitrile, respectively, to precipitate proteins. After cen-
trifugation at 4 ◦C, the supernatant was dried under N 2 gas. The
dried residue was dissolved in 100 μL Milli-Q water, 40 μL was
injected for LC-MS analysis. The LC-MS was acquired in a Dionex-
UltiMate 3000 HPLC using Thermo Scientiﬁc Hypersil GOLD C18 col-
umn (150 × 2.1 mm 2 ) with a guard column (Hypersil GOLD C18 5 μm,
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Fig. 5. Nitrite levels and viability in 4-HNE treated activated primary macrophage cells. 
(A) Nitrite levels were measured via Griess assay in cells simultaneously activated with 
500 ng / mL LPS and treated with varying concentrations of 4-HNE for 48 h (B) cell 
viability was measured using MTT assay. LPS-activated cells treated with DMSO were 
used as control. Experiments were performed at least 3 times and error bars represent 
standard error of mean. * P < 0.01. 
Fig. 6. A model for 4-HNE control of induced nitric oxide production. At low 4-HNE 
concentrations over long time periods, there is an Nrf2-dependent negative feedback 
loop that inhibits LPS-induced nitric oxide production with an inﬂection at approx- 
imately 1 μM (green region). At higher concentrations a positive feedback loop is 
present whereby increasing concentrations of 4-HNE in turn elicits higher concentra- 
tions of nitric oxide during a short time period (red region). 0 × 2.1 mm 2 ) combined with a 4000 Qtrap mass spectrometer (Ap- 
lied Biosystems, Foster City, CA). The chromatographic method was 
eveloped at 0.2 mL / min (i) from 0 to 25 min with a 1–45% gradi- 
nt of buffer B (95% acetonitrile, 5% water, and 0.25% formic acid) 
n buffer A (95% water, 5% acetonitrile, and 0.25% formic acid), (ii) 
rom 25 to 26 min with a 45–90% gradient of buffer B in buffer A, (iii) 
rom 26 to 31 min with 90% buffer B in buffer A, and (iv) from 31 
o 32 min with a decreasing 90–1% gradient of buffer B in buffer A, 
ith 10 min of equilibration with 99% buffer A before the next injec- 
ion. The 4000 QTrap mass spectrometer was operated under positive 
onization mode with the following source settings: turbo-ion-spray 
ource at 600 ◦C, N 2 nebulization at 65 psi, N 2 heater gas at 55 psi, 
urtain gas at 30 psi, collision-activated dissociation gas pressure held 
t high, turbo-ion-spray voltage at 5500 V, declustering potential at 
0 V, entrance potential at 10 V, collision energy at 50 V, and collision 
ell exit potential at 10 V. Data acquisition was performed in multiple 
eaction monitoring mode monitoring the transition of [ M + H ] + 
 / z 464 in Q1 to [MH −156] + m / z 308 (protonated GSH) in Q3 as
uantiﬁer. The internal standard precursor ion and product ion were 
t m / z 475 and 308, respectively. 
esults and discussion 
dentiﬁcation of a negative feedback loop for 4-HNE production. 
Our initial experiment examined whether 4-HNE could modulate 
nducible NO formation in RAW 264.7 (RAW) culture macrophages 
timulated with lipopolysaccharide (LPS). Using the standard Griess 
ssay, we measured NO production after a 24 h exposure to LPS and 
arious concentrations of 4-HNE to examine steady state levels of NO 
roduction ( Fig. 1 A, Supplementary Figs. S1 and S2 ). Surprisingly, we 
bserved a dramatic decrease in NO production at 4-HNE concentra- 
ions greater than 1 μM ( Fig. 1 A). The observed decrease in NO pro- 
uction is not gradual as demonstrated by the abrupt decrease of NO 
evels over concentration ranges as small as 2.5-fold. Further, the ob- 
erved effect cannot be attributed to toxicity ( Supplementary Fig. S3 ). 
his result is physiologically relevant given that the basal concen- 
rations of 4-HNE found ubiquitously throughout mammalian tissues 
ange from 100 nM to 1 μM [ 13 , 25 ]. The biological signiﬁcance of this 
nding becomes evident when considering the origins of LPO prod- 
cts. The initial hydrogen abstraction step in LPO is ascribed to the 
hemical reactivity of oxidants such as superoxide and NO. Because 
-HNE is inhibiting the formation of NO, it is effectively inhibiting its 
wn production by limiting the production of NO which is ultimately 
onverted to the family of oxidants responsible for non-enzymatic 
ipid peroxidation and consequently the production of 4-HNE. We 
ypothesized that these observations represent the discovery of a 
egative feedback loop for the production of 4-HNE through inhibi- 
ion of oxidant formation. 
To examine whether 4-HNE has an effect on the constitutively ex- 
ressed isoform (endothelial eNOS) in RAW 264.7 cells [ 40 ], we tested 
he effects of 4-HNE at various concentrations at earlier time-points 
efore iNOS expression could occur [ 9 ]. After 30 min of exposure 
o 4-HNE, no effect was observed in the nM to μM range, however 
t higher concentrations (9–10 mM, Fig. 1 B) a dramatic increase in 
O production was observed, with nitrite concentrations reaching 
reater than 20 μM. Since it takes at least 8 h to induce NO produc- 
ion ( Supplementary Fig. S1 ), the increase in NO observed at 30 min 
annot be attributed to stimulation via LPS. It is unclear whether this 
ffect is due to a speciﬁc activation of eNOS [ 41 ], or a secondary effect 
hat is related to the toxicity inherent in these high concentrations 
f 4-HNE [ 24 ]. Additional studies are required to further determine 
he mechanism for the observed spike in NO levels during the ﬁrst 
0 min in 4-HNE-treated RAW cells. Regardless, given our laboratory ’ s 
nterests in iNOS, we decided to further explore the mechanistic un- 
erpinnings of the observed negative feedback proﬁle. 
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 Speciﬁcity of 4-hydroxy-2-(E)-alkenal C9–C10 derivatives on NO 
inhibition. 
Our next experiment aimed to test whether the observed pheno-
type was speciﬁc for 4-HNE, or simply a non-speciﬁc effect derived
from the electrophilic nature of the molecule. To test this, several
4-hydroxy-2-( E )-alkenal derivatives with varied chain lengths ( C5–
C12 ) were synthesized and evaluated for inhibition of NO production
as above. 4-Hydroxy-2-( E )-pentenal ( C5 ) was synthesized via a minor
modiﬁcation of the reported procedure ( Fig. 2 A) [ 36 ]. The other 4-
hydroxy-2-( E )-alkenal derivatives ( C6–C12 ) were synthesized using
a new strategy inspired by Gardner et al. [ 15 ], which treats homo-
allylic alcohols of appropriate chain length with m -CPBA to afford
the 3,4-epoxyalcohols that are then oxidized with Dess–Martin pe-
riodinane. The resulting 3,4-epoxyaldehydes undergo an in situ α-
hydrogen elimination and concomitant epoxide opening forming of
the desired 4-hydroxy-2-( E )-alkenals. 
Evaluation of NO production in activated macrophages displayed
a clear pattern whereby the C9 (4-HNE) and C10 alkenals showed the
most pronounced decrease in NO production ( Fig. 2 B). This result was
not due to toxicity ( Supplementary Fig. S4 ), and points to the observed
negative feedback being selective for 4-HNE. The observation that
C10 is slightly more potent is clear and repeatable across multiple
concentrations. On this point, in our recent ﬁndings, we have found
the presence of glutathionylated C10 in rat liver and heart tissues, and
others have reported the presence of C10 in tissues [ 18 ]. It is plausible
that the similar molecular volume of C9 and C10 effectively renders
them identical in their effective modulation of signal transduction
pathways controlling macrophages for NO production in vivo . 
Mechanism of inhibition by 4-HNE of NO production 
From a mechanistic point of view, we proposed two possible ex-
planations for the observed phenotypes. The ﬁrst was that 4-HNE in-
hibited the enzymatic activity of iNOS, resulting in decreased NO pro-
duction; the second explanation is rationalized as a consequence of
decreased iNOS expression. To differentiate between these two pos-
sibilities we ﬁrst investigated the effect of varying 4-HNE concentra-
tions on recombinant murine iNOS. Activity was measured from the
conversion of radiolabeled L-arginine to L-citrulline using a standard
assay and quantiﬁed using scintillation counts per minute (CPM) [ 4 ].
We tested the activity of recombinant iNOS at various 4-HNE concen-
trations, which correlated to the inhibitory concentrations observed
in Fig. 2 A. Between 1 μM and 1 mM no appreciable perturbation to
iNOS activity was seen ( Fig. 3 A). 
From these data, we concluded that 4-HNE is not a direct enzy-
matic inhibitor of iNOS. To explore our alternate hypothesis, we exam-
ined iNOS expression utilizing immunoblot and quantitative RT-PCR
analysis of 4-HNE treated LPS-activated RAW macrophages. We ob-
served that iNOS protein levels were not detectable in cells treated
with 5 μM and above 4-HNE ( Fig. 3 B). This observation positively cor-
related with quantitative RT-PCR analysis ( Fig. 3 C) that showed a dose
dependent inhibition in iNOS transcript by 4-HNE. Taken together, it
is clear that the observed inhibition of oxidant formation is due to an
inhibition of expression of iNOS. This observation is consistent with
previous reported in other cell lines [ 17 , 39 ]. 
Activation of Nrf2 signaling by 4-HNE suppresses NO production. 
Previous reports have demonstrated that molecules which acti-
vate Nrf2 transcription also perturb iNOS expression [ 23 ]. Based on
these observations, we explored the hypothesis that 4-HNE inhibits
iNOS expression through the activation of Nrf2. Canonical activation
of Nrf2 typically involves a small molecule activator that will specif-
ically interact with the repressor protein, Keap1. When this occurs,
Nrf2 dissociates from Keap1, translocates to the nucleus and effectsthe transcription of genes containing an antioxidant response ele-
ment (ARE). To test whether 4-HNE affects nuclear translocation of
Nrf2, we performed immunoblot analysis of cytoplasmic and nuclear
Nrf2 protein in RAW macrophages treated with 4-HNE concentrations
ranging from 1 to 10 μM. As seen in Fig. 4 A, cytoplasmic Nrf2 protein
levels decreased in the presence of 1 μM 4-HNE, while nuclear Nrf2
protein levels increased in a dose-dependent manner after treatment
for 5 min. 
To further demonstrate Nrf2 activation by 4-HNE in RAW
macrophages, we performed a series of quantitative RT-PCR analyses
of the Nrf2 target genes: heme oxygenase (HO-1), NAD(P)H:quinone
(NQO1) and γ-glutamylcysteine synthetase (GCLC). Fig. 4 B, clearly
shows marked increases in transcription for all three, with HO-1 and
GCLC increasing 1.5-fold, while NQO1 gene expression increased 3-
fold. At concentrations of 5 μM and above, HO-1, NQO1 and GCLC
gene expression increased 2- to 3-fold relative to control. Previous
studies have shown that 4-HNE induces Nrf2 translocation [ 44 , 45 ],
but Nrf2 mediated iNOS suppression and subsequent inhibition of NO
production by 4-HNE has not been addressed. Taken together, these
results clearly implicate activation of Nrf2 transcription as a probable
mechanism to explain the observed changes in iNOS expression. 
To conﬁrm our proposed mechanism, we initiated a series of ex-
periments using primary macrophages derived from either wild-type
(wt), or Nrf2 deﬁcient mice (Nrf2 −/ −). We isolated bone marrow de-
rived macrophages (BMDMs) from wt and Nrf2 −/ − mice and activated
the cells with LPS. Activated BMDM were treated with 0.1–5 μM 4-
HNE for 48 h. In the presence of 5 μM 4-HNE, we observed the same
decrease in NO as in the RAW macrophages, albeit with a slightly
attenuated response ( Fig. 5 A). This decrease in NO was not due to
toxicity ( Fig. 5 B). However, in Nrf2 −/ − BMDMs, no appreciable differ-
ences were observed for NO production. Given the above experiment,
we can ascribe the observed ability of 4-HNE to suppress iNOS and
inhibit NO formation to be a direct result of Nrf2 activation. This is
further supported by a study demonstrating 4-HNE directly adducting
to transcriptional inhibitor Keap1 [ 26 ]. 
Here, we have demonstrated that 4-HNE modulates the produc-
tion of the biological oxidant NO, which can further react with other
species, such as superoxide, to form the powerful oxidants respon-
sible for lipid peroxidation. Further, we had provided evidence that
this effect is a result of the activation of the Nrf2 transcription factor.
We would postulate that this activation is as a result of 4-HNE di-
rectly adducting one of the surface cysteine residues of the repressor
protein, Keap1, which has been previously shown by others in other
systems [ 21 , 26 ]. We carefully considered alternate hypotheses in-
cluding whether the observed effects could have arisen downstream
of another process or as a result of a 4-HNE metabolite. To this end, we
evaluated the state of reduced intracellular glutathione, and observed
no appreciable difference ( Supplementary Fig. S5 ) [ 6 ]. Further, based
on our own work investigating the metabolic fate of 4-HNE we con-
cluded that it is highly probable that the active intracellular molecule
is 4-HNE [ 33 , 43 ]. 
The signiﬁcance of these observations is rooted in chemical pro-
cesses that lead to the formation of LPO products. As mentioned ear-
lier, the ﬁrst step in this process is radical hydrogen abstraction of
PUFA by reactive oxygen and reactive nitrogen substances (ROS and
RNS, respectively), leading to the production of NO directly and the
formation of 4-HNE in the presence of PUFAs. The ﬁnding that 4-HNE,
in turn, regulates the production of NO has the hallmark of a nega-
tive feedback pathway. We propose that these ﬁndings argue for an
evolved feedback pathway to control the concentration of 4-HNE (and
other LPO products) in tissues that express inﬂammatory mediators
(such as iNOS) indirectly via the production of ROS and RNS. 
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The fact that the observed inhibitory concentrations of 4-HNE cor- 
espond to the observed physiologic concentrations lends further cre- 
ence to our hypothesis that 4-HNE is an essential endogenous regu- 
ator of NO production mediated through Nrf2 activation. The signif- 
cance of our study is that we demonstrated the involvement of Nrf2 
n suppressing NO production in 4-HNE treated cells. Taken together 
e have devised a model of the expression control of 4-HNE as shown 
n Fig. 6 that would argue for the production of 4-HNE as a carefully 
egulated process with an observed negative feedback loop. High con- 
entrations of 4-HNE have been observed during oxidative stress and 
n many disease states (red region). However, at low concentrations 
ver long time periods, there is an Nrf2-dependent negative feedback 
oop that inhibits LPS-induced nitric oxide production with an inﬂec- 
ion at approximately 1 μM (green region) that is dependent on Nrf2. 
his model stands in contrast to views in the ﬁeld that see 4-HNE as 
 cytotoxic xenobiotic causative of multiple disease states. 
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